DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $383,658 | +35.6% | 31,268 | +31.9% | 0.00% | 0.0% |
| Q2 2023 | $282,942 | +58.4% | 23,697 | +77.3% | 0.00% | +100.0% |
| Q1 2023 | $178,677 | -36.6% | 13,364 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $281,847 | +7.2% | 13,097 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $263,000 | +34.2% | 13,145 | +20.3% | 0.00% | +100.0% |
| Q2 2022 | $196,000 | +75.0% | 10,929 | -3.2% | 0.00% | 0.0% |
| Q1 2022 | $112,000 | +13.1% | 11,294 | +92.7% | 0.00% | – |
| Q4 2021 | $99,000 | -30.8% | 5,860 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $143,000 | – | 6,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
| Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
| DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
| Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
| RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
| BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
| PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
| COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
| Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |